Novavax, Inc.
NVAX
$7.93
-$0.02-0.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 33.20% | -174.70% | 210.05% | 17.29% | -36.41% |
| Total Depreciation and Amortization | -1.44% | 14.09% | -8.36% | 12.53% | -4.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -446.71% | -36.72% | 45.17% | -56.49% | 12.81% |
| Change in Net Operating Assets | 7.11% | -145.45% | 236.29% | 169.09% | -212.77% |
| Cash from Operations | -19.58% | -146.08% | 476.12% | 52.74% | -345.80% |
| Capital Expenditure | -40.82% | 52.28% | 58.20% | 22.19% | 51.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -240.32% | 109.00% | -99,317.20% | -55.65% | -2.58% |
| Cash from Investing | 351.26% | 108.56% | -5,040.79% | 20.14% | 50.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -438.28% | -39.89% | -1.67% | 84.48% | -231.91% |
| Issuance of Common Stock | -- | -99.84% | 3,659.34% | -93.32% | -47.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | -3,427.84% | -100.04% | 4,286.95% | -94.14% | -49.07% |
| Foreign Exchange rate Adjustments | -277.79% | 3,964.10% | 94.72% | -201.30% | -68.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.53% | -153.59% | 327.17% | -6.45% | -155.62% |
